Pharmacology of Acid-Reducing Agents
10 Questions
6 Views

Pharmacology of Acid-Reducing Agents

Created by
@SmoothestMelodica

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Which of the following are types of acid-reducing agents? (Select all that apply)

  • Prostaglandin analogues (correct)
  • H2 antagonists (correct)
  • Proton pump inhibitors (correct)
  • Muscarinic antagonists (correct)
  • What is the prototype drug for H2 antihistamines?

    Cimetidine

    Which of the following drugs are examples of Proton Pump Inhibitors?

  • Misoprostol
  • Ranitidine
  • Omeprazole (correct)
  • Calcium Carbonate
  • What is the mechanism of action of Proton Pump Inhibitors?

    <p>They inhibit the H+K+ATPase enzyme, reducing gastric acid secretion.</p> Signup and view all the answers

    Cimetidine has a higher incidence of adverse effects compared to newer H2 blockers.

    <p>True</p> Signup and view all the answers

    What percentage of acid output can Cimetidine reduce over 24 hours?

    <p>60-70%</p> Signup and view all the answers

    Which of the following is a side effect of Cimetidine?

    <p>All of the above</p> Signup and view all the answers

    What is the role of Sucralfate in acid-related treatment?

    <p>It acts as an ulcer protective agent.</p> Signup and view all the answers

    Match the drug with its primary action:

    <p>Cimetidine = H2 antagonist Omeprazole = Proton pump inhibitor Sucralfate = Ulcer protective Sodium Bicarbonate = Neutralizing agent</p> Signup and view all the answers

    What is the bioavailability percentage of Cimetidine?

    <p>60-80%</p> Signup and view all the answers

    Study Notes

    Gastric Acid Reduction

    • H2 blockers: Cimetidine, Ranitidine, Famotidine, Roxatidine
    • Suppress all phases of gastric acid secretion, including basal, psychic, and neurogenic
    • Cimetidine is the prototype, it suppresses nocturnal basal gastric acid secretion more completely
    • H2 blockers can prevent ulceration due to stress or drugs

    Proton Pump Inhibitors

    • Omeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Esomeprazole are all PPIs.
    • Inhibit the final common step in gastric acid secretion
    • More effective than H2 blockers for acid-peptic disorders
    • Can totally abolish HCl secretion, both resting and stimulated
    • Omeprazole is the prototype, it is active at pH < 5
    • PPIs irreversibly inactivate H+K+ATPase enzyme
    • Acid secretion resumes only when new H+K+ATPase molecules are synthesized
    • PPIs also inhibit gastric mucosal carbonic anhydrase

    Antacids

    • Neutralize gastric acid
    • Systemic: Sodium Bicarbonate, Sod.Citrate
    • Non Systemic: Magnesium Hydroxide, Mag.Trisilicate, Aluminium Hydroxide Gel, Magaldrate, Calcium Carbonate

    Other Drugs For Acid Suppression

    • Anticholinergics: Pirezepine, Propantheline, Oxyphenonium

    • Prostaglandin Analogue: Misoprostol

    Ulcer Protectives

    • Sucralfate, Colloidal Bismuth subcitrate (CBS)

    Anti-H.Pylori Drugs

    • Amoxycillin, Clarithromycin, Metronidazole, Tinidazole, Tetracycline

    Cimetidine

    • 60-70% reduction of 24hr acid output
    • 60-80% bioavailability. First pass hepatic metabolism
    • Excreted in urine & bile
    • T1/2: 2-3hrs

    Adverse Effects of Cimetidine

    • Headache, dizziness, bowel upset, dry mouth, rashes
    • Confusion, restlessness, convulsions, coma
    • Bolus IV administration can release histamine resulting in bradycardia, arrhythmia, cardiac arrest
    • Cimetidine displaces dihydrotestosterone from its cytoplasmic receptor, increases prolactin levels, and decreases estradiol degradation by the liver
    • Transient rise in aminotransferases

    Cimetidine Drug Interactions

    • Inhibits CYP 450 enzymes
    • Interact with warfarin, phenobarbitone, theophylline and phenytoin
    • Antacids reduce absorption of H2 blockers
    • H2 Blockers reduce absorption of ketoconazole

    Ranitidine

    • 5x more potent than Cimetidine
    • Longer duration of action (> 24hrs of suppression)
    • Little effect outside the GIT, less permeability into the brain
    • Does not inhibit hepatic metabolism
    • Lower incidence of adverse effects overall

    Famotidine

    • Longer duration of action
    • T1/2: 2.5-3.5 hrs
    • 5-8 x more potent than Ranitidine
    • Low affinity for CYP-450
    • 40-50% bioavailability
    • 70% excreted unchanged

    Roxatidine

    • Twice as potent and longer acting than Ranitidine

    H2 Blockers in Duodenal Ulcers

    • Rapid and marked pain relief in 2-3 days
    • 60-85% heal at 4 weeks; 70-95% at 8 weeks
    • About ½ the patients relapse, maintenance therapy reduces the relapse rate by 15-20%/year

    H2 Blockers in Gastric Ulcers

    • Healing rates somewhat lower 50-75% at 8 weeks)
    • Can heal NSAID associated ulcers
    • Less effective than PPIs & Misoprostol

    H2 Blockers in Acute Stressful Conditions

    • Hepatic coma, severe burns, trauma, prolonged intensive care, asphyxia neonatorum, etc.
    • IV H2 blockers prevent gastric lesions and hemorrhage

    H2 Blockers in Zollinger-Ellison Syndrome

    • Gastrin secreting tumor
    • H2 blockers in high doses control hyperacidity, but relief is incomplete
    • PPIs are the drug of choice
    • Definitive treatment is surgical

    H2 Blockers in GERD

    • Afford symptomatic relief and facilitate healing of oesophageal erosions
    • 2-3 divided doses

    H2 Blockers in Prophylaxis of Aspiration Pneumonia

    • Preoperatively

    Omeprazole

    • Prototype PPI
    • Best taken empty stomach
    • Highly plasma protein bound
      • Rapidly metabolized in the liver
    • No dose adjustment required in elderly or renal/hepatic impairment
    • Secretion resumes gradually over 3-5 days after discontinuation

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Peptic Ulcers Notes PDF

    Description

    This quiz covers the mechanisms and classifications of various acid-reducing agents, including H2 blockers, proton pump inhibitors (PPIs), and antacids. It highlights the prototypes of each class and their effects on gastric acid secretion. Test your knowledge on these medications and their therapeutic uses in managing acid-peptic disorders.

    More Like This

    30 Stomach ANATOMY AND PHYSIOLOGY
    50 questions
    Chemistry Acid-Base Concepts Quiz
    24 questions
    Acid, Base or Salt? Flashcards
    22 questions
    Cosmetic Ingredients and Their Acid Values
    18 questions
    Use Quizgecko on...
    Browser
    Browser